Hemoglobin Testing Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

Hemoglobin Testing Market Size Analysis and Top Companies

The global hemoglobin testing market size is estimated at to hit around USD 5.26 billion by 2033 from USD 2.84 billion in 2024 with a CAGR of 7.10% from 2024 tpo 2033. The top companies operating in the hemoglobin testing market are DiaSys Diagnostic Systems, Masimo, ARKRAY, Fisher Scientific, Bayer Medical Care, Abbott Laboratories, Beckman Coulter Diagnostics, Danaher, F. Hoffmann-La Roche, ACON Laboratories, Diazyme Laboratories, Radiometer, EKF Diagnostics Holdings, Alere, Epinex Diagnostics, Bio-Rad Laboratories, Erba Diagnostics, Daiichi Biotech, Sysmex Corporation and Others.

Market Scope

Hemoglobin Testing Market Companies

• DiaSys Diagnostic Systems
• Masimo
• ARKRAY
• Fisher Scientific
• Bayer Medical Care
• Abbott Laboratories
• Beckman Coulter Diagnostics
• Danaher
• F. Hoffmann-La Roche
• ACON Laboratories
• Diazyme Laboratories
• Radiometer
• EKF Diagnostics Holdings
• Alere
• Epinex Diagnostics
• Bio-Rad Laboratories
• Erba Diagnostics
• Daiichi Biotech
• Sysmex Corporation

Recent Developments

• The Afinion 2 analyzer was introduced in the United States by Abbott in May 2018. The Afinion 2 analyzer is a portable, fast, multi-assay platform that makes it easier to evaluate hemoglobin A1c levels in human blood and produces accurate findings right at the point of treatment. The firm was able to diversify its array of hemoglobin testing devices thanks to these strategic actions.
• Alere Inc., a renowned manufacturer of point-of-care diagnostics, was acquired by Abbott in full in February 2016. The company was able to increase its market position in the point-of-care testing industry because to this strategic approach.

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344